(−5, +5) Year Analysis | |||||||||||
Overall | Group | Non-Group | Related | Unrelated | BIFR | Non-BIFR | |||||
ROA | Diff. | −0.0003 | 0.0061 | −0.0113 | −0.0043 | 0.0110 | 0.0323* | −0.0066 | |||
N | 62 | 39 | 23 | 46 | 16 | 10 | 52 | ||||
P-value | 0.4804 | 0.2326 | 0.1701 | 0.2901 | 0.2300 | 0.0786 | 0.1680 | ||||
ROE | Diff. | 0.0406 | 0.1931 | −0.2322* | 0.0008 | 0.1415 | 0.2997* | −0.0196 | |||
N | 53 | 34 | 19 | 38 | 15 | 10 | 43 | ||||
P-value | 0.3692 | 0.1179 | 0.0837 | 0.4981 | 0.1109 | 0.0784 | 0.4448 | ||||
CFFO/TA | Diff. | −0.0007 | 0.0062 | −0.0123 | −0.0011 | 0.0005 | 0.0015 | −0.0011 | |||
N | 59 | 37 | 22 | 44 | 15 | 10 | 49 | ||||
P-value | 0.4555 | 0.1839 | 0.1459 | 0.4386 | 0.4853 | 0.4682 | 0.4309 | ||||
Mat/Sales | Diff. | −0.0068 | −0.0120 | 0.0023 | −0.0062 | −0.0089 | 0.0299 | −0.0145 | |||
N | 58 | 37 | 21 | 44 | 14 | 10 | 48 | ||||
P-value | 0.2673 | 0.1898 | 0.4502 | 0.3185 | 0.3292 | 0.1574 | 0.1077 | ||||
Lab/Sales | Diff. | 0.0095*** | 0.0082* | 0.0117*** | 0.0102*** | 0.0072 | −0.0035 | 0.0122*** | |||
N | 58 | 37 | 21 | 44 | 14 | 10 | 48 | ||||
P-value | 0.0068 | 0.0689 | 0.0032 | 0.0043 | 0.2452 | 0.3293 | 0.0023 | ||||
Oh/Sales | Diff. | 0.0238** | 0.0201 | 0.0303* | 0.0218* | 0.0301 | −0.0390** | 0.0369*** | |||
N | 58 | 37 | 21 | 44 | 14 | 10 | 48 | ||||
P-value | 0.0340 | 0.1144 | 0.0752 | 0.0758 | 0.1221 | 0.0461 | 0.0062 | ||||
Tax/Sales | Diff. | −0.0046** | −0.0021 | −0.0093** | −0.0053* | −0.0024 | 0.0001 | −0.0056** | |||
N | 57 | 37 | 20 | 43 | 14 | 10 | 47 | ||||
P-value | 0.0321 | 0.2356 | 0.0227 | 0.0458 | 0.2120 | 0.4921 | 0.0226 | ||||
Int./Sales | Diff. | −0.0039 | −0.0115* | 0.0094** | 0.0021 | −0.0209* | −0.0161*** | −0.0016 | |||
N | 61 | 39 | 22 | 45 | 16 | 10 | 51 | ||||
P-value | 0.2253 | 0.0630 | 0.0399 | 0.3321 | 0.0765 | 0.0098 | 0.3983 | ||||
Sales/TA | Diff. | 0.0183 | 0.0638 | −0.0562 | 0.0038 | 0.0685 | 0.1837 | −0.0162 | |||
N | 58 | 36 | 22 | 45 | 13 | 10 | 48 | ||||
P-value | 0.3657 | 0.1718 | 0.2594 | 0.4730 | 0.3116 | 0.1293 | 0.3842 |